Faculty Disclosures
| Natalia S. Rost, MD, MPH, FAAN, FAHA |
Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care. |
| Nina F. Schor, MD, PhD, FAAN |
Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director, NINDS with National Institutes of Health. |
| Bruce H. Cohen, MD, FAAN |
Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for CoA Therapeutics/BioBridge. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abliva/NeuroVive. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis/Zogenix/USB. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision BioSciences . Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Pretzel. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Allergan. The institution of Dr. Cohen has received research support from Stealth Biotherapeutics. The institution of Dr. Cohen has received research support from BioElectron Technologies/PTC. The institution of Dr. Cohen has received research support from Astellas/MitoBridge. The institution of Dr. Cohen has received research support from Reneo Pharmaceuticals. The institution of Dr. Cohen has received research support from Abliva. The institution of Dr. Cohen has received research support from Tisento. Dr. Cohen has received publishing royalties from a publication relating to health care. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with US DOJ. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a CPT Advisor with AAN. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Foundation that is relevant to AAN interests or activities. |
| Serge Przedborski, MD, PhD |
Dr. Przedborski has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eLife. The institution of Dr. Przedborski has received research support from NIH. The institution of Dr. Przedborski has received research support from DoD. The institution of Dr. Przedborski has received research support from Ludwig Foudantion. The institution of Dr. Przedborski has received research support from CZI. |
| Sumit Parikh, MD |
Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care. |
| Hajime A. Tokuno, MD |
No disclosure on file
|
| Nicholas Blondin, MD |
Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc.. |
| Kenji Sekiguchi, MD, PhD |
Dr. Sekiguchi has nothing to disclose. |
| Cyril Goizet |
No disclosure on file
|
|
No disclosure on file
|
| Guilhem Sole, MD |
No disclosure on file
|
| Alexandra Durr, MD |
The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC. |
| Alexis Brice, MD |
Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM. |
| Fumio Kanda, MD, PhD, FAAN |
No disclosure on file
|
| Bruno Eymard, MD |
No disclosure on file
|
| Edoardo Malfatti, MD |
Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. |
| Senda Ajroud-Driss, MD, FAAN |
Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Ajroud-Driss has received research support from ALSA. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care. |
| Vladimir S. Kostic, MD, PhD |
Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of 好色先生, Science and Technological Development of Serbia. |
| Michio Hirano, MD, FAAN |
Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 好色先生. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities. |
| Hisatomo Kowa, MD, PhD |
No disclosure on file
|
| Michael E. Shy, MD, FAAN |
Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics. |
| Mario A. Saporta, MD, PhD, FAAN |
Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. |
| Ludwig Kappos, MD, FAAN |
The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care. |
| Ronald C. Petersen, MD, PhD, FAAN |
Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Darryl C. De Vivo, MD, FAAN |
Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics. |
| Rita Horvath, MD |
No disclosure on file
|
| Michelle M. Mezei, MD |
No disclosure on file
|
| Valentina Emmanuele, MD, PhD |
Dr. Emmanuele has nothing to disclose. |
| Pietro Iaffaldano |
No disclosure on file
|
| Maria Trojano |
Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. |
| Michael Greicius, MD |
Dr. Greicius has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acelot. Dr. Greicius has stock in SBGneuro. |
| Hidehiko Okazawa, MD, PhD |
No disclosure on file
|
| Sharmilee Gnanapavan, MB |
Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR. |
| David S. Silvers, MD, FAAN |
No disclosure on file
|
| Margherita Milone, MD, FAAN |
Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota. |
| Jason Valerio, MD |
No disclosure on file
|
| David S. Knopman, MD, FAAN |
Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Maria P. Amato, PhD |
Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche. |
| Christopher M. Everett, MBBS, PhD |
No disclosure on file
|
| A. H. Hewazy, FRCP (G), FRCP(L), F |
No disclosure on file
|
| Jana Godau, MD |
No disclosure on file
|
| Evangelia Sotiriou, MD |
No disclosure on file
|
| Jonathan W. Mink, MD, PhD, FAAN |
The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
| Pascal Laforet |
No disclosure on file
|
| Faisal Fecto, MD, PhD |
The institution of Dr. Fecto has received research support from NINDS. |
| Caterina Garone |
No disclosure on file
|
| Teepu Siddique, MD, FAAN |
No disclosure on file
|
| Tanya Stojkovic |
Tanya Stojkovic has nothing to disclose. |
| Anthony Behin |
No disclosure on file
|
| Massimo Filippi, MD, FAAN |
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Lee-jun C. Wong, PhD |
No disclosure on file
|
| Federica Agosta |
Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC. |
| Catarina Quinzii Hirano, MD |
No disclosure on file
|
| Takahiro Iizuka, MD |
The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd. |
| Junichi Hamada, MD, PhD |
No disclosure on file
|
| Beatriz Garcia-Diaz |
No disclosure on file
|
| Rebecca A. Harrison, MD |
No disclosure on file
|
| Matthis Synofzik |
Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD. |
| Makoto Yoneda |
No disclosure on file
|
| Masamichi Ikawa |
No disclosure on file
|
| Scott W. Andersen |
Scott W. Andersen, 19156 has received personal compensation for serving as an employee of Eli Lilly. Scott W. Andersen, 19156 has stock in Eli Lilly. Scott W. Andersen, 19156 has received personal compensation in the range of $100,000-$499,999 for serving as a Statistician with Eli Lilly. |
| Eric R. Siemers, MD |
Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities. |
| Michelle M. Mielke, PhD |
Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. |
| Heather Adams |
The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute. |